Phase I pharmacokinetic, food effect, and pharmacogenetic study of oral irinotecan given as semisolid matrix capsules in patients with solid tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/15746053

Clin. Cancer Res. 2005 Feb 15 11 4 1504-11

Download in:

View as

General Info

PMID
15746053